Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 119478-56-7 | Product Number: M2279
Meropenem Trihydrate
Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
1G |
82,00 €
|
8 | ≥80 |
|
5G |
287,00 €
|
2 | ≥60 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Product Number | M2279 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__7H__2__5N__3O__5S·3H__2O = 437.51 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 119478-56-7 |
Related CAS RN | 96036-03-2 |
PubChem Substance ID | 135727273 |
Merck Index (14) | 5900 |
MDL Number | MFCD08600005 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Specific rotation [a]20/D | -17.0 to -21.0 deg(C=0.44, H2O) |
Water | 11.4 to 13.4 % |
Properties (reference)
Specific Rotation | -18° (C=0.44,H2O) |
Solubility in water | Soluble |
GHS
Related Laws:
RTECS# | CL5446507 |
Transport Information:
HS Number | 2941900000 |
Application
Meropenem: A Carbapenem Antibiotic with Broad Spectrum of Activity and Stability to β-Lactamases
Meropenem, which is the second carbapenem antibiotic, has a broad spectrum of activity that includes activity against gram-positive bacteria and excellent gram-negative aerobic and anaerobic activity. It has enhanced gram-negative activity relative to imipenem (the first carbapenem antibiotic)-cilastatin and often retains activity against strains resistant to third-generation cephalosporins and imipenem-cilastatin. It has increased stability to β-lactamases compared with imipenem.
References
- Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
- Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems
- T. Köhler, M. Michea-Hamzehpour, S. F. Epp, J.-C. Pechere, Antimicrob. Agents Chemother. 1999, 43, 424.
- Meropenem: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy
- Comparative review of the carbapenems
- Meropenem: a review of its use in the treatment of serious bacterial infections
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.